Loading provider…
Loading provider…
Hematology & Oncology Physician in Ridgewood, NJ
NPI: 1376627737Primary Practice Location
VALLEY HOSPITAL
4 Valley Health Plz, Paramus, NJ
Primary Employer
Valley Physician Services PC
valleyhealth.com
HQ Phone
Get MD Eli's Phone Numberphone_androidMobile
Get MD Eli's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
Icahn School Of Medicine At Mount Sinai
icahn.mssm.edu
Residency • Internal Medicine
1987 - 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 312 | 553 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 138 | 306 |
| 3 | 99203New patient outpatient visit, total time 30-44 minutes | 92 | 92 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 76 | 97 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 64 | 64 |
Authors: Edgardo Santos, Geoffrey Oxnard, Lecia Sequist
Journal: Oncol Ther
Publication Date: 2018-05-25
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Nivolumab, DRUG: Cisplatin, DRUG: Etoposide
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: Incyte Corporation
Collaborators: AstraZeneca
Intervention / Treatment: DRUG: Osimertinib, DRUG: Itacitinib